Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Development of a portable hypoxia chamber for ultra-high dose rate laser-driven proton radiobiology applications

P. Chaudhary, DC. Gwynne, B. Odlozilik, A. McMurray, G. Milluzzo, C. Maiorino, D. Doria, H. Ahmed, L. Romagnani, A. Alejo, H. Padda, J. Green, D. Carroll, N. Booth, P. McKenna, S. Kar, G. Petringa, R. Catalano, FP. Cammarata, GAP. Cirrone, SJ....

. 2022 ; 17 (1) : 77. [pub] 20220415

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018773

Grantová podpora
EP/K022415/1 engineering and physical sciences research council
EPJ500094/1 engineering and physical sciences research council
EP/P010059/1 engineering and physical sciences research council
18HLT04 UHD european metrology programme for innovation and research
European Union's Horizon 2020 research horizon 2020 framework programme
innovation program under the Marie Sklowdowska-Curie grant agreement no 754507 horizon 2020 framework programme

BACKGROUND: There is currently significant interest in assessing the role of oxygen in the radiobiological effects at ultra-high dose rates. Oxygen modulation is postulated to play a role in the enhanced sparing effect observed in FLASH radiotherapy, where particles are delivered at 40-1000 Gy/s. Furthermore, the development of laser-driven accelerators now enables radiobiology experiments in extreme regimes where dose rates can exceed 109 Gy/s, and predicted oxygen depletion effects on cellular response can be tested. Access to appropriate experimental enviroments, allowing measurements under controlled oxygenation conditions, is a key requirement for these studies. We report on the development and application of a bespoke portable hypoxia chamber specifically designed for experiments employing laser-driven sources, but also suitable for comparator studies under FLASH and conventional irradiation conditions. MATERIALS AND METHODS: We used oxygen concentration measurements to test the induction of hypoxia and the maintenance capacity of the chambers. Cellular hypoxia induction was verified using hypoxia inducible factor-1α immunostaining. Calibrated radiochromic films and GEANT-4 simulations verified the dosimetry variations inside and outside the chambers. We irradiated hypoxic human skin fibroblasts (AG01522B) cells with laser-driven protons, conventional protons and reference 225 kVp X-rays to quantify DNA DSB damage and repair under hypoxia. We further measured the oxygen enhancement ratio for cell survival after X-ray exposure in normal fibroblast and radioresistant patient- derived GBM stem cells. RESULTS: Oxygen measurements showed that our chambers maintained a radiobiological hypoxic environment for at least 45 min and pathological hypoxia for up to 24 h after disconnecting the chambers from the gas supply. We observed a significant reduction in the 53BP1 foci induced by laser-driven protons, conventional protons and X-rays in the hypoxic cells compared to normoxic cells at 30 min post-irradiation. Under hypoxic irradiations, the Laser-driven protons induced significant residual DNA DSB damage in hypoxic AG01522B cells compared to the conventional dose rate protons suggesting an important impact of these extremely high dose-rate exposures. We obtained an oxygen enhancement ratio (OER) of 2.1 ± 0.1 and 2.5 ± 0.1 respectively for the AG01522B and patient-derived GBM stem cells for X-ray irradiation using our hypoxia chambers. CONCLUSION: We demonstrated the design and application of portable hypoxia chambers for studying cellular radiobiological endpoints after exposure to laser-driven protons at ultra-high dose, conventional protons and X-rays. Suitable levels of reduced oxygen concentration could be maintained in the absence of external gassing to quantify hypoxic effects. The data obtained provided indication of an enhanced residual DNA DSB damage under hypoxic conditions at ultra-high dose rate compared to the conventional protons or X-rays.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018773
003      
CZ-PrNML
005      
20220804135102.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s13014-022-02024-3 $2 doi
035    __
$a (PubMed)35428301
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Chaudhary, Pankaj $u The Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Lisburn Road, Belfast, BT9 7AE, Northern Ireland, UK. p.chaudhary@qub.ac.uk $u Centre for Plasma Physics, School of Mathematics and Physics, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK. p.chaudhary@qub.ac.uk $1 https://orcid.org/0000000203813635
245    10
$a Development of a portable hypoxia chamber for ultra-high dose rate laser-driven proton radiobiology applications / $c P. Chaudhary, DC. Gwynne, B. Odlozilik, A. McMurray, G. Milluzzo, C. Maiorino, D. Doria, H. Ahmed, L. Romagnani, A. Alejo, H. Padda, J. Green, D. Carroll, N. Booth, P. McKenna, S. Kar, G. Petringa, R. Catalano, FP. Cammarata, GAP. Cirrone, SJ. McMahon, KM. Prise, M. Borghesi
520    9_
$a BACKGROUND: There is currently significant interest in assessing the role of oxygen in the radiobiological effects at ultra-high dose rates. Oxygen modulation is postulated to play a role in the enhanced sparing effect observed in FLASH radiotherapy, where particles are delivered at 40-1000 Gy/s. Furthermore, the development of laser-driven accelerators now enables radiobiology experiments in extreme regimes where dose rates can exceed 109 Gy/s, and predicted oxygen depletion effects on cellular response can be tested. Access to appropriate experimental enviroments, allowing measurements under controlled oxygenation conditions, is a key requirement for these studies. We report on the development and application of a bespoke portable hypoxia chamber specifically designed for experiments employing laser-driven sources, but also suitable for comparator studies under FLASH and conventional irradiation conditions. MATERIALS AND METHODS: We used oxygen concentration measurements to test the induction of hypoxia and the maintenance capacity of the chambers. Cellular hypoxia induction was verified using hypoxia inducible factor-1α immunostaining. Calibrated radiochromic films and GEANT-4 simulations verified the dosimetry variations inside and outside the chambers. We irradiated hypoxic human skin fibroblasts (AG01522B) cells with laser-driven protons, conventional protons and reference 225 kVp X-rays to quantify DNA DSB damage and repair under hypoxia. We further measured the oxygen enhancement ratio for cell survival after X-ray exposure in normal fibroblast and radioresistant patient- derived GBM stem cells. RESULTS: Oxygen measurements showed that our chambers maintained a radiobiological hypoxic environment for at least 45 min and pathological hypoxia for up to 24 h after disconnecting the chambers from the gas supply. We observed a significant reduction in the 53BP1 foci induced by laser-driven protons, conventional protons and X-rays in the hypoxic cells compared to normoxic cells at 30 min post-irradiation. Under hypoxic irradiations, the Laser-driven protons induced significant residual DNA DSB damage in hypoxic AG01522B cells compared to the conventional dose rate protons suggesting an important impact of these extremely high dose-rate exposures. We obtained an oxygen enhancement ratio (OER) of 2.1 ± 0.1 and 2.5 ± 0.1 respectively for the AG01522B and patient-derived GBM stem cells for X-ray irradiation using our hypoxia chambers. CONCLUSION: We demonstrated the design and application of portable hypoxia chambers for studying cellular radiobiological endpoints after exposure to laser-driven protons at ultra-high dose, conventional protons and X-rays. Suitable levels of reduced oxygen concentration could be maintained in the absence of external gassing to quantify hypoxic effects. The data obtained provided indication of an enhanced residual DNA DSB damage under hypoxic conditions at ultra-high dose rate compared to the conventional protons or X-rays.
650    _2
$a DNA $x účinky záření $7 D004247
650    _2
$a lidé $7 D006801
650    _2
$a hypoxie $7 D000860
650    _2
$a lasery $7 D007834
650    _2
$a kyslík $7 D010100
650    12
$a protony $7 D011522
650    12
$a radiobiologie $7 D011853
655    _2
$a časopisecké články $7 D016428
700    1_
$a Gwynne, Deborah C $u Centre for Plasma Physics, School of Mathematics and Physics, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK
700    1_
$a Odlozilik, Boris $u Centre for Plasma Physics, School of Mathematics and Physics, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK $u ELI-Beamlines Centre, Institute of Physics, Czech Academy of Sciences, Za Radnicí 835, 252 41, Dolní Břežany, Czech Republic
700    1_
$a McMurray, Aaron $u Centre for Plasma Physics, School of Mathematics and Physics, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK
700    1_
$a Milluzzo, Giuliana $u Centre for Plasma Physics, School of Mathematics and Physics, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK $u Laboratori Nazionali del Sud - Istituto Nazionale di Fisica Nucleare, Via S Sofia 62, 95123, Catania, Italy
700    1_
$a Maiorino, Carla $u The Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Lisburn Road, Belfast, BT9 7AE, Northern Ireland, UK
700    1_
$a Doria, Domenico $u Centre for Plasma Physics, School of Mathematics and Physics, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK $u Extreme Light Infrastructure (ELI-NP) and Horia Hulubei National Institute for R & D in Physics and Nuclear Engineering (IFIN-HH), Str. Reactorului No. 30, 077125, Bucharest, Magurele, Romania
700    1_
$a Ahmed, Hamad $u Centre for Plasma Physics, School of Mathematics and Physics, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK $u Experimental Science Group, Central Laser Facility, Rutherford Appleton Laboratory, Didcot, Oxford, OX11 0QX, England, UK
700    1_
$a Romagnani, Lorenzo $u Laboratoire LULI, École Polytechnique, Route de Saclay, 91128, Palaiseau, Paris, France
700    1_
$a Alejo, Aaron $u Centre for Plasma Physics, School of Mathematics and Physics, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK
700    1_
$a Padda, Hersimerjit $u Department of Physics, SUPA, University of Strathclyde, Glasgow, G1 1XQ, Scotland, UK
700    1_
$a Green, James $u Experimental Science Group, Central Laser Facility, Rutherford Appleton Laboratory, Didcot, Oxford, OX11 0QX, England, UK
700    1_
$a Carroll, David $u Experimental Science Group, Central Laser Facility, Rutherford Appleton Laboratory, Didcot, Oxford, OX11 0QX, England, UK
700    1_
$a Booth, Nicola $u Experimental Science Group, Central Laser Facility, Rutherford Appleton Laboratory, Didcot, Oxford, OX11 0QX, England, UK
700    1_
$a McKenna, Paul $u Department of Physics, SUPA, University of Strathclyde, Glasgow, G1 1XQ, Scotland, UK
700    1_
$a Kar, Satyabrata $u Centre for Plasma Physics, School of Mathematics and Physics, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK
700    1_
$a Petringa, Giada $u Laboratori Nazionali del Sud - Istituto Nazionale di Fisica Nucleare, Via S Sofia 62, 95123, Catania, Italy
700    1_
$a Catalano, Roberto $u Laboratori Nazionali del Sud - Istituto Nazionale di Fisica Nucleare, Via S Sofia 62, 95123, Catania, Italy
700    1_
$a Cammarata, Francesco P $u Laboratori Nazionali del Sud - Istituto Nazionale di Fisica Nucleare, Via S Sofia 62, 95123, Catania, Italy
700    1_
$a Cirrone, Giuseppe A P $u Laboratori Nazionali del Sud - Istituto Nazionale di Fisica Nucleare, Via S Sofia 62, 95123, Catania, Italy
700    1_
$a McMahon, Stephen J $u The Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Lisburn Road, Belfast, BT9 7AE, Northern Ireland, UK
700    1_
$a Prise, Kevin M $u The Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Lisburn Road, Belfast, BT9 7AE, Northern Ireland, UK. k.prise@qub.ac.uk
700    1_
$a Borghesi, Marco $u Centre for Plasma Physics, School of Mathematics and Physics, Queen's University Belfast, Belfast, BT7 1NN, Northern Ireland, UK. M.Borghesi@qub.ac.uk
773    0_
$w MED00165460 $t Radiation oncology (London, England) $x 1748-717X $g Roč. 17, č. 1 (2022), s. 77
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35428301 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135055 $b ABA008
999    __
$a ok $b bmc $g 1822402 $s 1170016
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 17 $c 1 $d 77 $e 20220415 $i 1748-717X $m Radiation oncology $n Radiat. oncol. $x MED00165460
GRA    __
$a EP/K022415/1 $p engineering and physical sciences research council
GRA    __
$a EPJ500094/1 $p engineering and physical sciences research council
GRA    __
$a EP/P010059/1 $p engineering and physical sciences research council
GRA    __
$a 18HLT04 UHD $p european metrology programme for innovation and research
GRA    __
$a European Union's Horizon 2020 research $p horizon 2020 framework programme
GRA    __
$a innovation program under the Marie Sklowdowska-Curie grant agreement no 754507 $p horizon 2020 framework programme
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Možnosti archivace